Ryan Pearson’s team will explore how engineered nanoparticles can safely retrain the immune system to reduce allergic airway inflammation.

Computer modeling finds the most promising compounds and guides their transformation into drugs.

Study will explore how an antibiotic-resistant bacterium survives in the body and how that knowledge could lead to new, more effective treatments.

Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, of the School of Pharmacy is working to ensure drug delivery through the skin is safe and effective and just the right dose.

New cohorts in PSC and PHSR arrive as the School launches curriculum updates and deepens its commitment to research and student success.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.

Team approach is a win-win for researchers, patients.

Diverse cohort of scholars represent seven graduate programs.